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ABSTRACT   
BACKGROUND: Posterior Reversible Encephalopathy Syndrome 
(PRES) is a potentially reversible neurological disorder of acute to 
subacute onset characterized by headache, nausea and vomiting, 
visual disturbance, seizure and altered mental status. 
Neuroimaging findings are characteristic, which allow early 
diagnosis in the appropriate clinical setting and enable to institute 
appropriate therapy timely. 
CASE PRESENTATION: We report 3 adult patients with a history 
of hypertension presented with recurrent episode of seizure and 
altered mentation.While all the 3 patients were preliminarily 
diagnosed with Ischemic stroke, they were subsequently diagnosed 
with posterior reversible encephalopathy syndrome after 
neuroimaging revealed the typical features of the syndrome. They 
were started on antihypertensive and anticonvulsant drugs. On 
follow-up examination after 3-4 weeks, the patients showed marked 
clinical and neuro-imaging improvements. 
CONCLUSION: Posterior reversible encephalopathy syndrome is a 
rare condition. The presenting clinical symptoms are non-specific 
and may mimic other neurological disorders. Therefore, early 
recognition of classic radiographic features is vital to the diagnosis. 
Timely diagnosis and treatment of this syndrome is important as 
the treatment outcome is mostly favorable. 
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Posterior Reversible Encephalopathy Syndrome (PRES) is a rare 
neurological syndrome characterized by non-specific symptoms like 
headache, visual disturbance, seizures and altered mentation (1). 
Characteristic neuroimaging findings suggestive of vasogenic edema 
are non-enhancing, subcortical white matter abnormalities often seen 
bilaterally and predominantly inposterior cerebral hemispheres (2). 
In this report, we present three cases of PRES admitted to Tikur 
Anbessa Specialized Hospital over a year-long time period. All the 
three patients had uncontrolled hypertension and presented with new 
onset seizure and altered mentation. 
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A 17-year-old male, with a history of nephrotic 
syndrome and chronic hypertension for 4 years on 
prednisolone 10 mg and Enalapril 5 mg daily 
presented with recurrent attacks of generalized 
tonic clonic seizure and loss of consciousness for 
two hours. His blood pressure (BP) on admission 
was 180/100 mmHg and funduscopy revealed 
bilateral papilledema with blot hemorrhage on the 
right eye. The rest of neurologic and systemic 
examaminations were normal. 
He was started with anticonvulsant (diazepam 
and phenytoin), and antihypertensive (Nifedipine) 
was added. After stabilization, brain Magnetic 
Resonance Imaging (MRI) scan was taken; and it 
revealed T2 weighted hyperintense lesions in 
subcortical white matter involving the bilateral 
occipital, parietal, and high posterior frontal lobes 
without contrast enhancement, mass effect or 
associated diffusion restriction [Figure 1(A)].   
Clinically, he recovered gradually, and follow-up 
non-contrast head computerized tomography (CT) 
scan taken after 3 weeks showed complete 
resolution of previously noted abnormal signals 
[Figure 1(B)]. The diagnosis of PRES was made, 




A 52-years-old female, known hypertensive 
patient for 2 years naive to treatment presented 
with sudden onset global headache and blurred 
vision followed by loss of consciousness and 
generalized tonic-clonic seizure at home. 
At admission, her BP was 210/100mmHg, 
and antihypertensive drug was started. Her 
neurologic and general examination was normal. 
Brain MRI revealed symmetrical, T2-weighted 
hyperintense signals in bilateral occipital, parietal 
and posterior frontal lobes, without contrast 
enhancement [Figure 2(A& B)]. 
Tests for other causes of stroke were negative 
including Magnetic Resonance Venography 
(MRV). Her clinical condition improved and 
follow-up brain MRI after 4 weeks showed 
complete resolution of all white matter lesions 
[Figure 2(B)]. All these changes after optimal 
blood pressure control were consistent with PRES, 




A 55-year-old female, known bronchial asthma 
and hypertension patient on follow-up at our 
hospital, was admitted for acute exacerbation of 
asthma and took Intravenous hydrocortisone. On 
the next day, her respiratory symptom improved, 
but later that day, she had sever headache, blurred 
vision followed bygeneralized tonic-clonic seizure 
and loss of consciousness. By the time, her BP 
was 150/100mmHg, and antihypertensive drug 
was titrated and loaded with Phenytoin. 
Her brain MRI revealed bilateral, 
symmetrical T2 weighted hyperintensities in the 
subcortical white matter and overlying gray matter 
of posterior parietal and occipital lobeswith out 
contrast enhancement [Figure 3 (A)]. On follow-
up of brain MRI after 3 weeks, all previous 
abnormalties resolved completely [Figure 3(B)]. 
All the above changes were suggestive of PRES, 




The first case of PRES was described in 1996 by 
Hinchey et al (1). Recently, it is increasingly 
recognized due to more ready availability of MRI 
(3). 
The causes of PRES are diverse, but the 
common precipitants are acute elevation of blood 
pressure, renal failure and treatment with 
immunosuppressive drugs (1,3). Our study 
revealed a similar etiology with more than one risk 
factor identified in two of our participants, 
demonstrating how PRES might be multifactorial. 
PRES has been reported in almost all age 
groups but most frequently in young-or-middle-
aged adults with female predominance, likely 
resulting from difference in vascular reactivity to 
various hormones (4). Similarly, our study found 
more females with PRES. 
The most common clinical features are 
headache, vomiting, visual disturbance ranging 
from blurred vision to cortical blindness, and 
altered mentation including confusion, 
somnolence and coma. The onset is usually acute 
to subacute, and seizures are common initial 
symptoms which may begin focally but usually 
become generalized.The tendon reflexes are often 
brisk, and some patients have focal neurologic 
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deficits depending on the location of the lesion 
(1).  
The pathogenesis of PRES is poorly 
understood, but it is postulated that impaired 
autoregulation of cerebral blood vessels, leading 
to cerebral hyperperfusion and blood-brain barrier 
dysfunction causing vascular leakage and edema 
mainy in the posterior circulation where the 
sympathetic innervation is reduced. Another 
mechanism is direct toxic effect on the 
endothelium by circulating endogenous 
(preeclampsia, sepsis) or exogenous 
(chemotherapy, immunosuppressive agents) 
substances (3). 
The most common neuroimaging abnormality 
in PRES include sedema without infarction 
involving the subcortical white matter in the 
posterior cerebral hemispheres, especially the 
bilateral parietal and occipital regions.The 
calcarine and paramedian occipital lobe structures 
are usually spared; a fact that distinguishes PRES 
frombilateral posterior cerebral artery infarction 
(1). This lesion appears as areas of hypo- 
attenuation on CT scan, but MRI is the imaging 
modality of choice, which reveals T1-weighted 
hypointense and T2-weighted hyperintense areas, 
and iso- or-hypointense areas on diffusion 
weighted imaging (DWI) that partially or 
completely resolve on follow-up imaging. 
Involvement of other brain areas, such as the 
frontal lobes, brain stem, cerebellum and basal 
ganglia,have been reported in PRES patients (2). 
Both clinical and imaging findings are non-
specific. Therefore, the diagnosis of PRES is often 
made after excluding other mimickers like 
posterior circulation stroke, cerebral venous 
thrombosis, and leucoariosis. In the appropriate 
clinical scenario, a characteristic lesion on 
neuroimaging which showed a rapid clinical and 
imaging resolution with appropriate treatment is 
the hallmark of PRES (1,3). 
Although reversible by definition, secondary 
complications, such as ischemic infarction or 
intracranial hemorrhage, have been reported. The 
prognosis of PRES is favorable. Most patients 
recover completely in few days with early 
recognition and prompt treatment of the 
underlying cause. Neuroimaging findings may 
persist for weeks, although most imaging findings 
have been reported to resolve within eight days to 
seventeen months after the first abnormality (1). 
In conclusion, this case series highlights the 
need to consider PRES in the differential 
diagnosis of patients presented with acute 
neurological events and high blood pressure. To 
the best of our knowledge, this is the first case 
series on PRES reported from Ethiopia. 
Awareness of the characteristic neuro-imaging 
features of PRES is essential to avoid 
misdiagnosis and delayed treatment, since the 
clinical features are non-specific but the treatment 
outcome is mostly favorable. 
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Figure 1: A) Axial T2-Weighted image shows a hyperintense signal in deep and subcortical white matter in 
high frontal, parietal and bilateral occipital regions B) Follow-up Non contrast brain CT showed complete 
resolution of previously noted abnormal signals. 
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Figure 2: A and B) T2-weighted axial images shows hyperintense signals in subcortical white matter of 
bilateral occipital, parietal, and high posterior frontal lobes. B) Follow-up axial T2-weighted image shows 
complete resolution of all previously noted signal abnormalities. 
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Figure 3: A) Axial FLAIR image shows hyperintense signal in subcortical white matter and overlying gray 
matter of bilateral posterior parietal and occipital lobes B)Follow-up axial FLAIR image shows complete 
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